Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Feba S Sam

2PUBLICATIONS
13CO-AUTHORS
Molecular medicineBiomolecular modelling and design
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (2)

Sort by Publication Date:
|Oct 23, 2019
Repurposing the aldose reductase inhibitor and diabetic neuropathy drug epalrestat for the congenital disorder of glycosylation PMM2-CDG.

Sangeetha Iyer, Feba S Sam, Nina DiPrimio

|Oct 17, 2019
Drug screens of <i>NGLY1</i> deficiency in worm and fly models reveal catecholamine, NRF2 and anti-inflammatory-pathway activation as potential clinical approaches.

Sangeetha Iyer, Joshua D Mast, Hillary Tsang

Pageof 1

Frequent Collaborators

2 joint publications

Sangeetha Iyer

2 joint publications

Hillary Tsang

2 joint publications

Nina DiPrimio

2 joint publications

Zachary Parton

2 joint publications

Ethan O Perlstein

1 joint publications

Joshua D Mast

1 joint publications

Tamy P Rodriguez

1 joint publications

Madeleine Prangley

1 joint publications

Graeme Preston

1 joint publications

Jan Verheijen

Frequent Collaborators

2 joint publications

Sangeetha Iyer

2 joint publications

Hillary Tsang

2 joint publications

Nina DiPrimio

2 joint publications

Zachary Parton

Top Related Videos

<em>In Vitro</em> Enzyme Measurement to Test Pharmacological Chaperone Responsiveness in Fabry and Pompe Disease
10:16

<em>In Vitro</em> Enzyme Measurement to Test Pharmacological Chaperone Responsiveness in Fabry and Pompe Disease

Published on : Dec 20, 2017

8.5K
Application of a C. elegans Dopamine Neuron Degeneration Assay for the Validation of Potential Parkinson's Disease Genes
08:42

Application of a C. elegans Dopamine Neuron Degeneration Assay for the Validation of Potential Parkinson's Disease Genes

Published on : Jul 18, 2008

See more related videos

Top Related Videos

<em>In Vitro</em> Enzyme Measurement to Test Pharmacological Chaperone Responsiveness in Fabry and Pompe Disease
10:16

<em>In Vitro</em> Enzyme Measurement to Test Pharmacological Chaperone Responsiveness in Fabry and Pompe Disease

Published on : Dec 20, 2017

8.5K
Application of a C. elegans Dopamine Neuron Degeneration Assay for the Validation of Potential Parkinson's Disease Genes
08:42

Application of a C. elegans Dopamine Neuron Degeneration Assay for the Validation of Potential Parkinson's Disease Genes

Published on : Jul 18, 2008

See more related videos